Structures by: Eltayeb N. E.
Total: 49
(<i>Z</i>)-2-(5-Fluoro-2-oxoindolin-3-ylidene)-<i>N</i>-methylhydrazinecarbothioamide
C10H9FN4OS
IUCrData (2016) 1, 4 x160659
a=5.70580(10)Å b=10.6201(2)Å c=18.8688(4)Å
α=90° β=90° γ=90°
Methyl 5-(4-hydroxyphenyl)-6-oxo-1,6-dihydropyrazine-2-carboxylate monohydrate
C12H10N2O4,H2O
IUCrData (2016) 1, 11 x161741
a=3.7072(3)Å b=11.4251(9)Å c=14.3713(13)Å
α=70.748(4)° β=88.425(5)° γ=83.284(5)°
Methyl 5-(4-hydroxyphenyl)-6-oxo-1,6-dihydropyrazine-2-carboxylate
C12H10N2O4
IUCrData (2016) 1, 11 x161689
a=23.9226(19)Å b=7.1372(6)Å c=13.0562(11)Å
α=90° β=99.158(5)° γ=90°
4-Methyl-<i>N</i>-[(4-methylpyridin-2-yl)carbamothioyl]benzamide
C15H15N3OS
Acta Crystallographica Section E (2015) 71, 3 315-317
a=11.5297(12)Å b=6.1860(6)Å c=20.657(2)Å
α=90.00° β=101.431(2)° γ=90.00°
<i>trans</i>-Dichloridobis[<i>N</i>-(5,5-dimethyl-4,5-dihydro-3<i>H</i>-pyrrol-2-yl-κ<i>N</i>)acetamide]palladium(II) dihydrate
C16H28Cl2N4O2Pd,2(H2O)
Acta Crystallographica Section E (2017) 73, 4 528-530
a=15.945(12)Å b=8.765(6)Å c=16.894(13)Å
α=90° β=101.481(19)° γ=90°
(<i>E</i>)-1-naphthaldehyde oxime
C11H9NO
Acta Crystallographica Section E (2018) 74, 3 332-336
a=7.928(5)Å b=4.843(3)Å c=11.444(7)Å
α=90° β=94.03(5)° γ=90°
<i>E</i>-phenanthrene-9-carbaldehyde oxime
C15H11NO
Acta Crystallographica Section E (2018) 74, 3 332-336
a=8.2397(8)Å b=4.9728(5)Å c=13.9332(14)Å
α=90° β=106.680(7)° γ=90°
Chlorido{5,5-dimethoxy-2,2'-[1,2-phenylenebis(nitrilomethylidyne)]diphenolato-κ^4^<i>O</i>,<i>N</i>,<i>N</i>',<i>O</i>'}manganese(III)
C22H18ClMnN2O4
Acta Crystallographica Section E (2008) 64, 5 m670-m671
a=13.7282(2)Å b=15.0250(2)Å c=19.2094(3)Å
α=90.00° β=90.00° γ=90.00°
Bis[5,6-diphenyl-3-(2-pyridyl)-1,2,4-trizine-κ^2^N,N]manganese(II) monohydrate
C40H28Cl2MnN8,H2O
Acta Crystallographica Section E (2006) 62, 9 m2284-m2286
a=24.610(5)Å b=16.166(3)Å c=8.9590(17)Å
α=90.00° β=90.00° γ=90.00°
Tetraaquatetrakis{μ~3~-6,6-dioxido-2,2'-[1,2-phenylenebis(nitrilomethylidyne)]diphenolato}octazinc(II) dimethyl sulfoxide tetrasolvate dihydrate
C80H56N8O20Zn8,4(C2H6OS),2(H2O)
Acta Crystallographica Section E (2008) 64, 7 m912-m913
a=18.1324(3)Å b=18.1324(3)Å c=13.3813(3)Å
α=90.00° β=90.00° γ=90.00°
Chlorido{6,6-dimethyl-2,2'-[1,2-phenylenebis(nitrilomethylidyne)]diphenolato- κ^4^<i>O</i>,<i>N</i>,<i>N</i>',<i>O</i>'}manganese(III) monohydrate
C22H18ClMnN2O2,H2O
Acta Crystallographica Section E (2008) 64, 4 m535-m536
a=27.1836(6)Å b=6.80330(10)Å c=21.8896(4)Å
α=90.00° β=108.9760(10)° γ=90.00°
Chlorido{5,5-dimethyl-2,2'-[1,2-phenylenebis(nitrilomethylidyne)]diphenolato-κ^4^<i>O</i>,<i>N</i>,<i>N</i>',<i>O</i>'}manganese(III)
C22H18ClMnN2O2
Acta Crystallographica Section E (2008) 64, 4 m570-m571
a=20.9593(5)Å b=13.5897(3)Å c=14.9316(3)Å
α=90.00° β=119.6410(10)° γ=90.00°
(Acetone-κ<i>O</i>){6,6-di-<i>tert</i>-butyl-2,2'-[1,2-phenylenebis(nitrilomethylidyne)]diphenolato-κ^4^<i>O</i>,<i>N</i>,<i>N</i>',<i>O</i>'}zinc(II)
C31H36N2O3Zn
Acta Crystallographica Section E (2008) 64, 5 m738-m739
a=10.5803(16)Å b=16.3602(19)Å c=15.729(2)Å
α=90.00° β=94.446(10)° γ=90.00°
2-{(<i>E</i>)-({2-[(1<i>E</i>)-(2,4-Dihydroxybenzylidene)amino]phenyl}iminiomethyl)-5-hydroxyphenolate methanol solvate
C20H16N2O4,CH4O
Acta Crystallographica Section E (2008) 64, 7 o1246-o1247
a=8.3672(2)Å b=11.0813(2)Å c=20.3217(3)Å
α=89.3130(10)° β=80.3090(10)° γ=79.6410(10)°
2,2'-{1,2-phenylenebis(nitrilomethylidyne)}bis(4,6-di-<i>tert</i>-butylphenol) acetone solvate
C36H48N2O2,C3H6O
Acta Crystallographica Section E (2008) 64, 3 o576-o577
a=10.0008(2)Å b=12.0020(3)Å c=17.0366(4)Å
α=82.0680(10)° β=86.3200(10)° γ=65.7640(10)°
Aquachlorido{6,6-di-<i>tert</i>-butyl-2,2'-[1,2-phenylenebis(nitrilomethylidyne)]diphenolato-κ^4^<i>O</i>,<i>N</i>,<i>N</i>',<i>O</i>'}manganese(III)—–chlorido{6,6'-di-<i>tert</i>-butyl-2,2'-[1,2-phenylenebis(nitrilomethylidyne)]diphenolato-κ^4^<i>O</i>,<i>N</i>,<i>N</i>',<i>O</i>'}(methanol-κ<i>O</i>)manganese(III) (1/1)
C29H34ClMnN2O3,C28H32ClMnN2O3
Acta Crystallographica Section E (2008) 64, 5 m626-m627
a=13.1080(3)Å b=13.8794(3)Å c=14.6085(3)Å
α=95.1770(10)° β=99.9960(10)° γ=95.6390(10)°
3-[1-(3-Hydroxybenzyl)-1<i>H</i>-benzimidazol-2-yl]phenol
C20H16N2O2
Acta Crystallographica Section E (2009) 65, 6 o1374-o1375
a=10.5128(2)Å b=12.1096(2)Å c=12.5235(2)Å
α=90.00° β=96.9480(10)° γ=90.00°
2-Methyl-6-(6-methyl-1<i>H</i>-benzimidazol-2-yl)phenol--2-methyl-6-(5-methyl-1<i>H</i>-benzimidazol-2-yl)phenol (3/1)
0.75(C15H14N2O),0.25(C15H14N2O)
Acta Crystallographica Section E (2009) 65, 12 o3227-o3228
a=4.92310(10)Å b=19.8900(6)Å c=12.3199(3)Å
α=90.00° β=105.0850(10)° γ=90.00°
Chlorido{4,4,6,6'-tetra-<i>tert</i>-butyl-2,2'-[<i>o</i>- phenylenebis(nitrilomethylidyne)]diphenolato- κ^4^<i>O</i>,<i>N</i>,<i>N</i>',<i>O</i>'}manganese(III)
C36H46ClMnN2O2
Acta Crystallographica Section E (2009) 65, 12 m1692-m1693
a=10.7650(6)Å b=16.8997(9)Å c=20.2324(11)Å
α=107.357(3)° β=90.010(3)° γ=107.294(3)°
2-((<i>E</i>)-{2-[(<i>E</i>)-2,3-Dihydroxybenzylideneamino]-5- methylphenyl}iminiomethyl)-6-hydroxyphenolate
C21H18N2O4
Acta Crystallographica Section E (2009) 65, 9 o2065-o2066
a=17.0634(2)Å b=21.3455(2)Å c=20.0291(2)Å
α=90.00° β=99.9820(10)° γ=90.00°
2-Methoxy-6-(6-methyl-1<i>H</i>-benzimidazol-2-yl)phenol
C15H14N2O2
Acta Crystallographica Section E (2009) 65, 7 o1613-o1614
a=14.4118(2)Å b=14.4118(2)Å c=12.0995(2)Å
α=90.00° β=90.00° γ=90.00°
6,6'-Di-<i>tert</i>-butyl-2,2'-[1,2-phenylenebis(nitrilomethylidyne)]diphenol
C28H32N2O2
Acta Crystallographica Section E (2009) 65, 12 o3142-o3143
a=6.8312(9)Å b=13.9632(16)Å c=14.0689(15)Å
α=116.615(5)° β=99.068(4)° γ=98.209(4)°
(<i>E</i>)-4-Allyl-2-[(2-hydroxyphenyl)iminiomethyl]-6-methoxyphenolate
C17H17NO3
Acta Crystallographica Section E (2010) 66, 4 o934-o935
a=14.719(3)Å b=9.1302(16)Å c=20.597(4)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-4-Chloro-2-[(2-hydroxyphenyl)iminomethyl]phenol
C13H10ClNO2
Acta Crystallographica Section E (2010) 66, 5 o1065-o1066
a=4.6681(9)Å b=18.509(3)Å c=6.2118(11)Å
α=90.00° β=90.980(4)° γ=90.00°
(<i>E</i>)-4-Bromo-2-[(2-hydroxyphenyl)iminiomethyl]phenolate
C13H10BrNO2
Acta Crystallographica Section E (2010) 66, 6 o1262-o1263
a=4.6387(3)Å b=18.9379(13)Å c=6.2270(4)Å
α=90.00° β=90.144(3)° γ=90.00°
(<i>E</i>)-4-Hydroxy-2-[(2-hydroxyphenyl)iminiomethyl]phenolate
C13H11NO3
Acta Crystallographica Section E (2010) 66, 7 o1536-o1537
a=11.048(5)Å b=8.187(3)Å c=22.858(10)Å
α=90.00° β=102.242(13)° γ=90.00°
(<i>E</i>)-2-[(2,4-Dihydroxybenzylidene)azaniumyl]-3-(1<i>H</i>-indol- 3-yl)propanoate monohydrate
C18H16N2O4,H2O
Acta Crystallographica Section E (2011) 67, 8 o2113-o2114
a=8.4214(3)Å b=10.6787(4)Å c=18.9554(8)Å
α=90.00° β=90.00° γ=90.00°
4-(5,6-Dihydrobenzimidazo[1,2-<i>c</i>]quinazolin-6-yl)benzene-1,3-diol dimethyl sulfoxide monosolvate
C20H15N3O2,C2H6OS
Acta Crystallographica Section E (2011) 67, 7 o1721-o1722
a=9.9310(18)Å b=16.342(3)Å c=23.516(5)Å
α=90.00° β=90.00° γ=90.00°
(<i>Z</i>)-2-(2-Oxoindolin-3-ylidene)-<i>N</i>-phenylhydrazinecarbothioamide
C15H12N4OS
Acta Crystallographica Section E (2012) 68, 4 o962-o963
a=6.36740(10)Å b=15.4594(3)Å c=14.2199(3)Å
α=90.00° β=93.3830(10)° γ=90.00°
(<i>Z</i>)-2-(5-Chloro-2-oxoindolin-3-ylidene)-<i>N</i>- methylhydrazinecarbothioamide
C10H9ClN4OS
Acta Crystallographica Section E (2012) 68, 4 o964-o965
a=6.25580(10)Å b=10.14490(10)Å c=18.5682(2)Å
α=90.00° β=90.00° γ=90.00°
4-Methyl-<i>N</i>-[2-(pyridin-2-yl)ethylcarbamothioyl]benzamide
C16H17N3OS
Acta Crystallographica Section E (2014) 70, 8 o885
a=16.0467(12)Å b=4.8824(4)Å c=23.0403(18)Å
α=90.00° β=124.997(5)° γ=90.00°
(<i>E</i>)-2-{[1-Carboxy-2-(1<i>H</i>-indol-3-yl)ethyliminio]methyl}-6- hydroxyphenolate
C18H16N2O4
Acta Crystallographica Section E (2011) 67, 9 o2389
a=8.4351(2)Å b=9.3038(3)Å c=9.5023(3)Å
α=90.00° β=98.683(2)° γ=90.00°
[2-(1<i>H</i>-Benzimidazol-2-yl-κ<i>N</i>^3^)aniline-κ<i>N</i>]dichloridozinc
C13H11Cl2N3Zn
Acta Crystallographica Section E (2011) 67, 8 m1062-m1063
a=22.0252(7)Å b=10.0651(3)Å c=15.3676(6)Å
α=90.00° β=125.244(2)° γ=90.00°
2-(5,6-Dihydrobenzimidazo[1,2-<i>c</i>]quinazolin-6-yl)-6-ethoxyphenol
C22H19N3O2
Acta Crystallographica Section E (2011) 67, 9 o2519
a=8.6935(3)Å b=10.9167(3)Å c=11.3401(5)Å
α=107.193(2)° β=108.923(2)° γ=104.723(2)°
2-(5,6-dihydrobenzimidazo[1,2-<i>c</i>]quinazolin-6-yl)5-methoxyphenol
C21H17N3O2
Acta Crystallographica Section E (2011) 67, 9 o2410-o2411
a=9.54080(10)Å b=15.6503(2)Å c=11.76090(10)Å
α=90.00° β=110.4080(10)° γ=90.00°
2-(5,6-Dihydrobenzimidazo[1,2-<i>c</i>]quinazolin-6-yl)phenol
C20H15N3O
Acta Crystallographica Section E (2011) 67, 9 o2243-o2244
a=17.1513(10)Å b=19.1160(11)Å c=9.2630(5)Å
α=90.00° β=97.5900(10)° γ=90.00°
(2-{[2-(1<i>H</i>-Benzimidazol-2-yl-κ<i>N</i>^3^)phenyl]iminomethyl-κ<i>N</i>}-5-methylphenolato-κ<i>O</i>)chloridozinc(II)
C21H16ClN3OZn
Acta Crystallographica Section E (2011) 67, 9 m1182-m1183
a=8.63380(10)Å b=19.4952(2)Å c=10.96870(10)Å
α=90.00° β=99.6750(10)° γ=90.00°
2-(5,6-Dihydrobenzimidazo[1,2-<i>c</i>]quinazolin-6-yl)-5-methylphenol
C21H17N3O
Acta Crystallographica Section E (2011) 67, 9 o2373-o2374
a=15.1292(3)Å b=12.2648(2)Å c=17.1909(3)Å
α=90.00° β=96.2330(10)° γ=90.00°
(<i>Z</i>)-2-(5-Chloro-2-oxoindolin-3-ylidene)-<i>N</i>- phenylhydrazinecarbothioamide
C15H11ClN4OS
Acta Crystallographica Section E (2011) 67, 12 o3141-o3142
a=5.7117(2)Å b=17.9510(7)Å c=14.2455(5)Å
α=90.00° β=91.262(2)° γ=90.00°
(<i>Z</i>)-2-(5-Methyl-2-oxoindolin-3-ylidene)-<i>N</i>- phenylhydrazinecarbothioamide
C16H14N4OS
Acta Crystallographica Section E (2011) 67, 12 o3476-o3477
a=5.6875(3)Å b=17.9405(8)Å c=14.5658(6)Å
α=90.00° β=91.105(3)° γ=90.00°
(<i>E</i>)-2-[(<i>E</i>)-3-(Hydroxyimino)butan-2-ylidene]-<i>N</i>- methylhydrazinecarbothioamide
C6H12N4OS
Acta Crystallographica Section E (2012) 68, 1 o184
a=5.52050(10)Å b=8.6077(2)Å c=9.5650(2)Å
α=79.7500(10)° β=89.5090(10)° γ=85.0830(10)°
Bis{<i>N</i>-ethyl-2-[3-(hydroxyimino-κ<i>N</i>)butan-2- ylidene]hydrazinecarbothioamide-κ^2^<i>N</i>^2^,<i>S</i>}nickel(II) dichloride
C14H28N8NiO2S22,2(Cl)
Acta Crystallographica Section E (2012) 68, 2 m183-m184
a=18.4990(11)Å b=14.2097(9)Å c=9.2422(6)Å
α=90.00° β=98.5420(10)° γ=90.00°
Bis{2-[3-(hydroxyimino-κ<i>N</i>)butan-2-ylidene]-<i>N</i>- methylhydrazinecarbothioamide-κ^2^<i>N</i>^2^,<i>S</i>}nickel(II) dichloride
C12H24N8NiO2S22,2(Cl)
Acta Crystallographica Section E (2012) 68, 2 m108-m109
a=8.94840(10)Å b=13.8043(2)Å c=35.4643(5)Å
α=90.00° β=95.7800(10)° γ=90.00°
(<i>Z</i>)-2-(5-Fluoro-2-oxoindolin-3-ylidene)-<i>N</i>- phenylhydrazinecarbothioamide
C15H11FN4OS
Acta Crystallographica Section E (2012) 68, 2 o285-o286
a=14.8736(7)Å b=17.4346(9)Å c=18.1756(10)Å
α=90.00° β=116.023(3)° γ=90.00°
(<i>Z</i>)-<i>N</i>-Methyl-2-(5-nitro-2-oxoindolin-3- ylidene)hydrazinecarbothioamide
C10H9N5O3S
Acta Crystallographica Section E (2012) 68, 4 o953-o954
a=4.6316(4)Å b=9.3157(8)Å c=26.458(2)Å
α=90.00° β=94.485(2)° γ=90.00°
(<i>Z</i>)-<i>N</i>-Methyl-2-(5-methyl-2-oxoindolin-3- ylidene)hydrazinecarbothioamide
C11H12N4OS
Acta Crystallographica Section E (2012) 68, 4 o955-o956
a=6.2826(2)Å b=10.0341(3)Å c=19.1315(5)Å
α=90.00° β=90.00° γ=90.00°
Bis[2-(2-oxoindolin-3-ylidene)-<i>N</i>-phenylhydrazinecarbothioamidato- κ^3^<i>O</i>,<i>N</i>^2^,<i>S</i>]nickel(II) dimethylformamide monosolvate
C30H22N8NiO2S2,C3H7NO
Acta Crystallographica Section E (2012) 68, 5 m538-m539
a=12.2491(2)Å b=12.3170(3)Å c=13.1142(2)Å
α=104.8540(10)° β=112.9430(10)° γ=102.7980(10)°
(<i>E</i>)-<i>N</i>-Ethyl-2-[(<i>E</i>)-3-(hydroxyimino)butan-2- ylidene]hydrazinecarbothioamide
C7H14N4OS
Acta Crystallographica Section E (2012) 68, 8 o2552
a=5.7065(2)Å b=9.0632(3)Å c=10.7109(4)Å
α=71.3090(10)° β=76.3180(10)° γ=86.4200(10)°
(<i>Z</i>)-<i>N</i>-Ethyl-2-(5-fluoro-2-oxoindolin-3- ylidene)hydrazinecarbothioamide
C11H11FN4OS
Acta Crystallographica Section E (2012) 68, 10 o2868-o2869
a=4.51510(10)Å b=11.6102(3)Å c=22.3255(7)Å
α=90.00° β=90.00° γ=90.00°